To assess whether there is a difference in endogenous insulin secretion, measured as
stimulated C-peptide secretion (area under the curve during a 4-hour mixed meal tolerance
test), at the 1 year visit, for study subjects receiving combinational therapy versus those
receiving placebo. The study will also examine the effect of the proposed treatments on
immunological outcomes, specifically proportion of regulatory T cells at the 1 year visit.